Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

NEOGENOMICS INC Director's Dealing 2021

Jan 11, 2021

32227_dirs_2021-01-11_16ac5bf1-050a-4f07-8683-212620dca52c.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEOGENOMICS INC (NEO)
CIK: 0001077183
Period of Report: 2021-01-07

Reporting Person: JONES STEVEN C (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-01-07 Common Stock M 100000 $7.15 Acquired 1100000 Indirect
2021-01-07 Common Stock M 10000 $7.27 Acquired 82932 Direct
2021-01-07 Common Stock M 3017 $11.60 Acquired 85949 Direct
2021-01-07 Common Stock M 4269 $22.52 Acquired 90218 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-01-07 Stock Option (Right to Buy) $7.15 M 100000 Disposed 2021-04-20 Common Stock (100000.0) Indirect
2021-01-07 Stock Option (Right to Buy) $7.27 M 10000 Disposed 2022-05-25 Common Stock (10000.0) Direct
2021-01-07 Stock Option (Right to Buy) $11.6 M 3017 Disposed 2023-06-01 Common Stock (3017.0) Direct
2021-01-07 Stock Option (Right to Buy) $22.52 M 4269 Disposed 2026-06-06 Common Stock (4269.0) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 125000 Indirect
Common Stock 30476 Indirect
Common Stock 40757 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (Right to Buy) $28.54 2027-05-28 Common Stock (3448.0) 3448 Direct

Footnotes

F1: This filing relates to the exercise of a stock option. No shares of Common Stock were sold by the Mr. Jones, and the shares of Common Stock received upon exercise of the stock option are subject to a lock-up agreement with BofA Securities, Inc, .Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC.

F2: Aspen Select Opportunity Fund is a private investment fund of which Aspen Capital Group, LLC is the sole general partner. Mr. Jones is a Managing Member of Aspen Capital Group, LLC. Mr. Jones disclaims beneficial ownership of such shares except to the extent of his respective pecuniary interests therein.

F3: On April 20, 2016, Mr. Jones was granted 100,000 stock options. The options vested ratably over the first three anniversary dates of the grant date. On December 30, 2019, Mr. Jones transferred these options to Aspen Select Opportunity Fund, LP.

F4: On May 25, 2017, Mr. Jones was granted 10,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.